Download Full Text (250 KB)
Multiple Myeloma: Increasing Response, Remission, and Survival Rates in a Complex Disease
House Call: A Guide to Radiation Therapy
In Brief: Researchers Enhance Anticancer Activity of Natural Killer Cells in Laboratory
Beyond Images: Advances in Interventional Radiology
Radioembolotherapy Using Yttrium 90
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
The University of Texas MD Anderson Cancer Center
Alexanian, Raymond; Orlowski, Robert; Murthy, Ravi; Gupta, Sanjay (Radiologist); Ahrar, Kamran; Hicks, Marshall; Wallace, Michael; Eng, Cathy; Nunez, Rodolfo; Lee, Dean; Zhu, Shiguo; Cooper, Laurence J.N.; Histone Deacetylase Inhibitors; Radiotherapy; Radiofrequency Ablation; Radiology, Interventional; Embolization, Therapeutic; Neoplasms; Liver Neoplasms; Neoplasm Metastasis; Yttrium-90; Killer Cells, Natural; Proteasome Inhibitors; entinostat; Valproic Acid; Bortezomib; Thalidomide; Clinical Trial as Topic; Lenalidomide; Lung Neoplasms.
History of Science, Technology, and Medicine | Oncology
LeBas, John and Hosemann, Sunni, "OncoLog Volume 53, Number 07/08, July/August 2008" (2008). OncoLog MD Anderson's Report to Physicians (All issues). 172.
Conditions Governing Access